Work

Safety and tolerability of guadecitabine (SGI-110) plus cisplatin in patients (pts) with platinum-refractory germ cell tumors (GCT): Preliminary results from an open label phase 1b study.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.e16545

Authors: Neda Hashemi-Sadraei, Lawrence H. Einhorn, Susan Perkins, Michael J Spinella, Fang Fang, Nasser H. Hanna, Kenneth P Nephew, Costantine Albany

Institutions: Indiana University School of Medicine, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Illinois Urbana-Champaign, Indiana University Bloomington

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891842102

Cites:

Cited by:

Related to: 10